Use of Real-World Data for in-silico Trials and Innovative Designs: Recent Successes and Current Perspectives

1 minute read

Published: October 2nd, 2025

Real-world data (RWD) are transforming clinical research. By supplementing randomized controlled trials (RCTs), RWD can de-risk studies and improve generalizability. Innovative designs, from hybrid RCTs to registry-based trials, are gaining traction, with regulators setting clear standards for their use.

This webinar shares case studies, practical methodologies, and key considerations to help you apply RWD effectively while balancing risks and opportunities.

Speakers:
  • Billy Amzal, Head of Strategic Consulting
  • Wei Liu (Moderator), Associate Director of Biostatistics
Learning Points :
  • When are innovative trial designs using RWD most appropriate?
  • How can technical and regulatory feasibility be assessed?
  • What RWD sources are most suitable?
  • Which statistical methods offer the best fit in these studies?
Complete the form below to access the recording and slides:

Related articles

DMC Best Practices: What Biotechs and Sponsors Should Know  

DMC Best Practices: What Biotechs and Sponsors Should Know  

August 5th, 2025 1 minute read

Data Monitoring Committees (DMC) are a critical part of the clinical trial process, independently assessing the safet...

Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials

Harnessing Bayesian Methods: Tackling Challenges in Rare Disease and Small Population Trials

May 27th, 2025 1 minute read

Sponsors working in rare diseases/running small population studies often have difficulties in demonstrating efficacy ...

Leveraging Real-World Evidence: Data Sources, Challenges and Applications in Modern Clinical Trials

Leveraging Real-World Evidence: Data Sources, Challenges and Applications in Modern Clinical Trials

April 29th, 2025 1 minute read

Real World Evidence (RWE) plays a critical role across multiple pharma processes, including drug development, regulat...